In vivo evaluation of the EZH2 inhibitor (EPZ011989) alone or in combination with standard of care cytotoxic agents against pediatric malignant rhabdoid tumor preclinical models—A report from the Pediatric Preclinical Testing Consortium

2020 ◽  
Vol 68 (2) ◽  
Author(s):  
Raushan T. Kurmasheva ◽  
Stephen W. Erickson ◽  
Eric Earley ◽  
Malcolm A. Smith ◽  
Peter J. Houghton
2014 ◽  
Vol 207 (9) ◽  
pp. 452 ◽  
Author(s):  
Yafang Hu ◽  
Daniel Bobb ◽  
Jianping He ◽  
Jeffrey S. Dome

2004 ◽  
Vol 10 (17) ◽  
pp. 5940-5948 ◽  
Author(s):  
Yasumichi Kuwahara ◽  
Hajime Hosoi ◽  
Shinya Osone ◽  
Masakazu Kita ◽  
Tomoko Iehara ◽  
...  

2018 ◽  
Vol 11 (3) ◽  
pp. 795-810 ◽  
Author(s):  
Hana Golan ◽  
Rachel Shukrun ◽  
Revital Caspi ◽  
Einav Vax ◽  
Naomi Pode-Shakked ◽  
...  

2014 ◽  
Vol 207 (9) ◽  
pp. 403-411 ◽  
Author(s):  
Yafang Hu ◽  
Daniel Bobb ◽  
Yunbiao Lu ◽  
Jianping He ◽  
Jeffrey S. Dome

2005 ◽  
Vol 25 (1_suppl) ◽  
pp. S598-S598 ◽  
Author(s):  
Laurent Martarello ◽  
Vincent J Cunningham ◽  
Julian C Matthews ◽  
Eugenii Rabiner ◽  
Steen Jakobsen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document